Meaning the drug Prolanta doesnt really exist? Sorry, but thats not the case.
In fact, I believe there's enough material right now on Prolanta that ONCX should be considered. For a phase 1 company observing evidence of efficacy in late stage, pretreated ovarian cancer patients using low dose Prolanta without Chemo, thats significant stuff especially considering ONCX's valuation
Theres quite a bit more about Prolanta available from the right sources. A capable person conducting DD can find this out
What I havent found "officially" is the exact evidence of efficacy.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.